Please login to the form below

Not currently logged in
Email:
Password:

Schmittgall wins Omega contract

German agency will lead promotion of several key products
Schmittgall logo

Germany's Omega Pharma has hired Schmittgall to promote several of its key products.

Schmittgall is to design campaigns for XLS Medical, Wartner and Opticalm. The agency will be responsible for TV, print, online and above and below the line campaigns for XLS Medical, Omega Pharma confirmed.

XLS is Europe's number one weight loss brand, growing strongly in Germany's pharmacy-exclusive slimming products market.

“With XLS Medical, we are assuming communications responsibility for a strong brand that has the makings of a star in its market,” said Schmittgall managing director OTC Wolf Stroetmann.

Schmittgall won the contract following a competitive pitch.

“Schmittgall convinced us strategically and creatively with a strong multi-channel concept,” said Omega Pharma head of marketing Stefan Kurt Bach.

Based in Stuttgart, the Schmittgall Group has some 100 employees, and focusses on multichannel healthcare marketing for the RX, OTC and healthcare services categories, Stroetmann told PMLiVE.

The biggest privately owned German healthcare advertising agency, its clients include Lilly, Reckitt Benckiser and Merck Serono.

Omega Pharma previously worked with Karlsruhe-based agency Sense & Image, which produced recent TV campaigns for XLS Medical and Wartner, and a trade and consumer campaign for Opticalm.

Article by
Tara Craig

30th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics